studies that have reported on outcomes after adjusting for socioeconomic status revealed a persistent, 22% higher mortality hazard for African-American women, independent of income bracket, age, and disease stage at the time of diagnosis. 5 Other factors that have been implicated in the etiology of these outcome disparities include higher obesity rates among African Americans, with Ͼ 50% of African Americans age Ͼ 40 years reported to be obese 6 ; higher dietary fat intake/poorer overall nutritional status 7 ; and menstrual/reproductive factors.
The younger age distribution for African-American patients with breast carcinoma has been a particularly disturbing feature because of the general impression that early-onset breast carcinoma represents an inherently more aggressive disease. However, even within the category of very young patients, breast carcinoma tends to imply a worse prognosis among African-American women. 8, 9 This pattern of early-onset disease, coupled with breast carcinoma characterized by higher rates of aneuploidy and hormone receptor negativity, also is observed for breast carcinoma detected in western African nations such as Nigeria and Ghana. 10 -14 This region of continental Africa shares a common ancestry with many African Americans, because it was a principal component of the colonial-era slave trade.
The parallels in breast carcinoma occurrence between African-American women and western continental African women suggest the influence of some asyet unidentified founder mutations in breast carcinoma susceptibility genes or in genes related to hormone metabolism. It also is possible that environmental exposures or lifestyle factors of disproportionate prevalence in the African-American community have an effect on primary breast tumor biology that currently remains undefined. Progress in the study of these theories will require the application of advanced molecular biologic techniques, including microarray analyses of tumor genetic content.
Elledge et al. conducted a landmark immunohistochemistry analysis of nearly 5000 breast tumors in a mixed-ethnicity tumor bank in 1994 15 : They found higher rates of estrogen receptor negativity and in- 1 have come to appreciate the need to go beyond observations of crude disease incidence and mortality rates if we are to ever develop meaningful insights regarding ethnicity-related variations in breast carcinoma burden. Jones et al. and the Yale University team of epidemiologists and pathologists studied the primary invasive breast tumors of 145 African-American patients with breast carcinoma and 177 white patients with breast carcinoma.
1 They utilized immunohistochemical staining to analyze the expression of p53, HER-2, and c-met in addition to the more routinely reported estrogen receptor/progesterone receptor status and tumor grade. This study represents important new information regarding the increased prevalence of p53 alterations in AfricanAmerican patients with breast carcinoma. The well established patterns of advanced stage distribution, higher nuclear grade tumors, and negative hormone receptor status also were observed. Table 1 summarizes the results of Jones et al. as well as a few selected studies that also have applied innovative tumor analyses to the study of breast carcinoma in African-American women. 1, [15] [16] [17] [18] [19] [20] Determining whether any of these observations are reproducible or are in fact random findings will require the repetition of these analyses in other patient populations. The critical message, however, is that the door to the improved understanding of ethnicity-related variation in breast carcinoma risk and outcome has now been wedged open by the powerful tools of molecular biology. It is our responsibility as clinicians and investigators to accept the challenge of conducting the studies, collecting and interpreting the data, and validating the results. Hopefully, the return from our success in meeting this challenge will be the ability to lower risk and improve the treatment efficacy for our collective, diverse patient populations.
